English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Result Anti-tuberculosis drugs can bind within the peptide binding grooves of HLA-B*57:01, HLA-A*02:06 and HLA-A*02:03 alleles and thereby alter its specificity. In the docking simulations, the interactions were found between HLA-A*02:01 and sulfasalazine , streptomycin , oflaxacin at Asp54, Ile237, Glu236, Lys267, Glu256, Thr238 And Val255 with -6.43 kcal/mol, -5.86 kcal/mol and -5.83 kcal/mol binding energy. HLA-A*02:06, HLAB*57:01 and HLA-A*02:03 have interaction with oflaxacin at Arg6, Lys58, Tyr51 and Arg72 with binding energies of -5.72 kcal/mol, -5.79 kcal/mol and -5.15 kcal/mol respectively. Conclusion The ultimate translation of this knowledge of how Antituberculosis drugs interact with HLA would be applicable to preclinical drug screening programs to improve the safety and cost effectiveness of drug design and development.

Risk assessment studies on HLA association with drug induced hypersensitivity caused by anti tuberculosis drugs – an in silico approach